Finance

Beta
Lists
Q910:FRA
Annexin Pharmaceuticals AB (publ)
€1.15
+2.68%
(+0.030) 1D
Jul 16, 8:04:06 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for Q910...
Open
€1.15
High
€1.15
Low
€1.15
Mkt. cap
113.79M
Avg. vol.
114.00
Volume
0.00
52-wk high
€2.80
52-wk low
€1.03
No. of employees
4
Open
€1.15
High
€1.15
Low
€1.15
Mkt. cap
113.79M
Avg. vol.
114.00
Volume
0.00
52-wk high
€2.80
52-wk low
€1.03
No. of employees
4
News stories
From sources across the web
About Annexin Pharmaceuticals AB (publ)
CEO-
Employees4
Founded2014
Headquarters-
SectorPharmaceutical industry
Websiteannexinpharma.se
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.10M
7.05M
8.00M
7.92M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.56M
2.35M
2.26M
2.90M
Operating expense
8.41M
9.40M
10.26M
10.82M
Total operating expenses
8.41M
9.40M
10.26M
10.82M
Operating income
-8.41M
-9.40M
-10.26M
-10.82M
Other non operating income
-
-
-
-
EBT including unusual items
-8.50M
-9.90M
-10.52M
-10.52M
EBT excluding unusual items
-8.50M
-9.90M
-10.52M
-10.52M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-259.00K
-
-
-
Net income
-8.50M
-9.90M
-10.52M
-10.52M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
80.00K
154.00K
231.00K
34.00K
Interest expense
-
-
-
-
Net interest expenses
80.00K
154.00K
231.00K
34.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.36M
-9.35M
-10.21M
-10.77M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer